Study: Tea(m)Time - Strengthening the Team Resilience of Hospital Staff Through the Tea(m)Time Intervention
NCT ID: NCT06694584
Last Updated: 2024-12-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
150 participants
INTERVENTIONAL
2024-03-04
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
Receives no intervention
No interventions assigned to this group
Tea(m)Time
Tea(m)Time intervention: Tea(m)Time is divided into two phases, starting with the qualification of team leaders.
The qualification is followed by the implementation of Tea(m)Time in the various teams.
Tea(m)Time
Tea(m)Time is divided into two phases, starting with the qualification of team leaders. This starts with knowledge transfer about healthy leadership, resilience, occupational health and safety, posture work, psychological empowerment, agile management and the role of the manager. The team leaders also learn various moderation/coaching techniques. The qualification is followed by the implementation of Tea(m)Time. The teams start each hour with self-reflection. This is followed by a stress assessment and prioritization. The teams then work on the problems identified and look for solutions together.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tea(m)Time
Tea(m)Time is divided into two phases, starting with the qualification of team leaders. This starts with knowledge transfer about healthy leadership, resilience, occupational health and safety, posture work, psychological empowerment, agile management and the role of the manager. The team leaders also learn various moderation/coaching techniques. The qualification is followed by the implementation of Tea(m)Time. The teams start each hour with self-reflection. This is followed by a stress assessment and prioritization. The teams then work on the problems identified and look for solutions together.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* have sufficient knowledge of German
* are not on sick leave at time t0
* work in one of the planned clinics
Exclusion Criteria
* do not have sufficient knowledge of German
* are on sick leave at time t0
* do not work in one of the planned clinics
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Catholic University of Applied Sciences Mainz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ivonne Ledtermann
research assistant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nadine Ungar, Dr.
Role: PRINCIPAL_INVESTIGATOR
Professorship for Psychology in Healthcare
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinik Viktoriastift Bad Kreuznach
Bad Kreuznach, , Germany
Geriatrische Fachklinik Rheinhessen-Nahe
Bad Kreuznach, , Germany
Gesundheitszentrum Glantal
Meisenheim, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Frank Müller
Role: primary
André Hennig
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-034
Identifier Type: -
Identifier Source: org_study_id